Fenfluramine: all 22 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Using Fenfluramine to Test the Serotonin Deficiency Theory of DepressionNot yet recruitingNCT07651293Not applicable
- A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeRecruitingNCT07503444Phase 3
- The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome ProjectRecruitingNCT07112365Phase 4
- Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgeRecruitingNCT06598449Phase 4
- Treatment of Refractory Infantile Spasms With FenfluramineRecruitingNCT04289467Phase 2
- A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study ParticipantsCompletedNCT06679413Phase 1Results posted
- A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut SyndromeCompletedNCT03936777Phase 3Results posted
- Fenfluramine in CDKL5 Deficiency Disorder (CDD)CompletedNCT03861871Phase 2Results posted
- Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).CompletedNCT03790137Phase 3Results posted
- A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromeCompletedNCT03355209Phase 3Results posted
- A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet SyndromeTerminatedNCT03299842Phase 3Results posted
- A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet SyndromeCompletedNCT02926898Phase 3Results posted
- An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromeCompletedNCT02823145Phase 3Results posted
- A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeCompletedNCT02682927Phase 3Results posted
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet SyndromeCompletedNCT06118255Phase 3
- Fenfluramine for Adult Dravet PatientsTerminatedNCT05560282Phase 3
- Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic OutcomesCompletedNCT05232630Phase 4
- A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.Active, not recruitingNCT05064878Phase 3
- Fenfluramine and CognitionCompletedNCT05026398Phase 4
- A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking CannabidiolCompletedNCT03467113Phase 1
- Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut EpilepsyCompletedNCT02655198Phase 2
- Predictive Values of Serotonergic Alterations for Outcome - 2TerminatedNCT00000313Phase 1